CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![Doctors discussing patient data-GettyImages-2214031965]( "Subject Matter Experts Matter In Decision-Making")
Subject Matter Experts Matter In Decision-MakingExpert-led ontology and taxonomy practices help organize data into meaningful hierarchies, making it easier to connect diseases, drug targets, and strategic insights that support stronger decisions.
-
![GettyImages-820772090 eyes]( "Clinical Trial Data Quality In Neurology Studies")
Clinical Trial Data Quality In Neurology StudiesDiscover how standardized ocular biomarkers and point-of-need delivery safeguard data integrity in complex neurology trials while keeping patients engaged.
-
![GettyImages-2032712502-scientists-tablet-training-labratory]( "Endpoint Adjudication Best Practices: What Top Teams Do Differently")
Endpoint Adjudication Best Practices: What Top Teams Do DifferentlyPoorly designed endpoint adjudication risks trial delays and data errors. Learn to optimize your process by aligning data capture, finalizing charters early, and using true arbitration.
-
![programming, digital transformation, binary code-GettyImages-1321462048]( "Bridging The Gap Between Protocol And Execution In Clinical Trials")
Bridging The Gap Between Protocol And Execution In Clinical TrialsTransform passive trial operations into active infrastructure. Learn how a digitized execution layer builds in compliance, enables effective AI, and frees teams for critical decision-making.
-
![GettyImages-2166551077-AI-Artificial Intelligence-hands]( "AI's Bottleneck In Clinical Trials Moved, And Most People Missed It")
AI's Bottleneck In Clinical Trials Moved, And Most People Missed ItAI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials7/5/2026
Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Enabling organizations of all sizes to transform their business through better use of technology.
Developing a therapy for a rare or ultra-rare disease is life-changing work with unique challenges. Examine how natural history data is being used to inform the clinical development process.
Accelerate Medical Writing Without Compromising Accuracy or Compliance
In the fast-paced world of clinical research, the ability to produce, review, and finalize high-quality documents—on time and with full regulatory compliance—is non-negotiable. Ideagen Document Review (formerly known as PleaseReview) is the trusted collaboration and co-authoring platform that enables clinical teams to streamline document reviews, reduce version chaos, and ensure traceable, auditable feedback across the board.
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
What can 22,000 people with an AI-mindset accomplish?
Speed without shortcuts
AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.
Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:
- Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
- Apply insights with agility to enable better decision-making
- Enhance data handling to drive first-time quality through content generation and workflow automation
It’s about time.
Modern ePRO/eCOA.
Solved.
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
CENTRAL LABORATORIES SOLUTIONS
- Modernize Clinical Research With Continuous Digital Data
- Trial Results Summaries
- Advarra Cloud
- Drive Patient Enrollments With Data-Powered Recruitment Engine
- The Next-Generation Of Clinical Trial Data Management And Operations
- NDA/MAA Preparation Survival Guide: Overcoming Data Analysis Hurdles
- Data-Powered Financial Management For Your Clinical Trials
- How AI Is Setting A New Standard In Clinical Development
- Measuring A Wide Range Of CNS Effects In A Pharmacological Context
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
VIDEOS
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- Endpoint Named A Leader In Everest Group's 2025 Life Sciences RTSM Products PEAK Matrix Assessment
- Human Abuse Potential: Subjective Ratings
- Human Abuse Potential: Participant Recruitment
- Why Now? The Case For Disruptive Technology In Clinical Trials
NEWS
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Univo IRB And The Patient View Announce Partnership
- Avance Clinical Launches Diversity In STEM Scholarships Across Australia And North America
- Lindus Health And Quotient Sciences Partner To Accelerate Drug Development From First-In-Human To Pivotal Trials
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience